Journals / Annals of Medical Sciences / 2001 / Cilt: 10 - Sayı: 4

Ultrastructural features of myocardium in progressive systemic sclerosis

Pages
151–155
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In accordance with the Ultrastructural observations it could be assumed that mast cells might be a factor in the pathogenesis of PSS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The present study involves with Ultrastructural changes of myocardium obtained from patients with progressive systemic sclerosis.
📊
Key Findings & Data:Methods: Cardiac catheterization was performed in 11 patients with progressive systemic sclerosis.
💡
Conclusion & Impact:Conclusion: In accordance with the Ultrastructural observations it could be assumed that mast cells might be a factor in the pathogenesis of PSS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The present study involves with Ultrastructural changes of myocardium obtained from patients with progressive systemic sclerosis. Methods: Cardiac catheterization was performed in 11 patients with progressive systemic sclerosis. Myocardial biopsy samples were obtained from the right ventricular apex via femoral venous approach and processed for electron microscopy using conventional method. Results: Myofibrillar degeneration, mitochondrial abnormalities, reduplication of capillary basal lamina, increasement of collagen fibers and abundant mast cells containing dense or pale granules were the main Ultrastructural alterations. Conclusion: In accordance with the Ultrastructural observations it could be assumed that mast cells might be a factor in the pathogenesis of PSS.

🔖

Cite This Article

METE, U. Ö., USAL, A., KAYA, M. (2022). Ultrastructural features of myocardium in progressive systemic sclerosis. Annals of Medical Sciences, Cilt: 10 - Sayı: 4, 151–155. https://ajindex.com/articles/447458

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Lee EB, Anhalt GJ, Voorhees JJ and Diaz LA: Patho-genesis of scleroderma. Int J Dermatol, 1984; 23: 85-89. 2.Haustein UF, Herrmann K and Böhme HJ: Pathogenesis of progressive systemic sclerosis. Int J Dermatol, 1986; 25: 286-293. 3.Moore EC, Cohen F, Farookız and Chang C: Focal scle-roderma and severe cardiomyopathy. AJDC, 1991; 145: 229-231. 4.Lawrence ME, Robinson JC and Teery EE: Progressive systemic sclerosis causing rapidly progressive myocardial disease and death. South Med J, 1992; 85: 770-772. 5.Fujimoto S, Kagoshima T, Nakajima T and Dohi K: Doppler echocardiographic assessment of left ventricular diastolic function in patients with progressive systemic sclerosis. Cardiology, 1993; 83: 217-227. 6.Lichtbroun AS, Sandhaus LM, Giorno RC, Kim H. and Seibold JR: Myocardial mast cells in systemic sclerosis: a report of three fatal cases. Am J Med, 1990; 89: 372-376. 7.Fleischmajer R, Perlish JS and West WP: Ultrastructure of cutaneous cellular infiltrates in scleroderma. Arch Dermatol, 1977; 113: 1661-1666. 8.Fleischmajer R and Perlish JS: Capillary alterations in scleroderma. J Am Acad Dermatol, 1980; 2: 161-170. 9.Neumark T: Ultrastructural study of neuromuscular and vascular changes in connective tissue disease. Int J Tiss Reac, 1986; 8:111-117. 10.Chen ZY, Virella G, Tung HE, Ainsworths K, Silver RM, Wang AC, Lavia MF, Maricq HR and Dobson RL: Im-mune complexes and antinuclear, antinucleolar, and anti-centromere antibodies in scleroderma. J Am Acad Der-matol,1984;11: 461-467. 11.Claman HN: Mast cell changes in a case of rapidly pro-gressive scleroderma-ultrastructural analysis. J Invest Dermatol,1989; 92: 290-295. 12.Harrison NK, Myers AR, Corrin B, Soosay G, Dewar A, Black CM, Dubois RM and Turner- Warcik M: Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis, 1991; 144: 706-71